These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33474640)

  • 41. Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review.
    Issaka RB; Avila P; Whitaker E; Bent S; Somsouk M
    Prev Med; 2019 Jan; 118():113-121. PubMed ID: 30367972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bundling Colorectal Cancer Screening Outreach with Screening for Social Risk in Federally Qualified Health Centers: A Stepped-Wedge Implementation-Effectiveness Study.
    Kruse GR; Percac-Lima S; Barber-Dubois M; Davies ME; Gundersen DA; Ho O; Mascioli L; Munshi M; Perry S; Singh D; Thomas A; Emmons KM; Haas JS
    J Gen Intern Med; 2024 May; 39(7):1188-1195. PubMed ID: 38332440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.
    Green BB; Baldwin LM; West II; Schwartz M; Coronado GD
    J Prim Care Community Health; 2020; 11():2150132720958525. PubMed ID: 32912056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.
    Somsouk M; Rachocki C; Mannalithara A; Garcia D; Laleau V; Grimes B; Issaka RB; Chen E; Vittinghoff E; Shapiro JA; Ladabaum U
    J Natl Cancer Inst; 2020 Mar; 112(3):305-313. PubMed ID: 31187126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness and Cost-effectiveness of Mailed FIT in a Safety Net Clinic Population.
    Pignone M; Lanier B; Kluz N; Valencia V; Chang P; Olmstead T
    J Gen Intern Med; 2021 Nov; 36(11):3441-3447. PubMed ID: 33929646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colorectal Cancer Screening with Mailed Fecal Immunochemical Tests and Telephone Outreach at a Community Health Center during the COVID-19 Pandemic.
    Ritzenthaler D; Deshpande S; Ryan M; Daprano J
    J Health Care Poor Underserved; 2022; 33(2):973-983. PubMed ID: 35574888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.
    Coronado GD; Thompson JH; Petrik AF; Nyongesa DB; Leo MC; Castillo M; Younger B; Escaron A; Chen A
    J Am Board Fam Med; 2019; 32(3):318-328. PubMed ID: 31068396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating Two Evidence-Based Intervention Strategies to Promote CRC Screening Among Latino Adults in a Primary Care Setting.
    Castañeda SF; Bharti B; Espinoza-Giacinto RA; Sanchez V; O'Connell S; Muñoz F; Mercado S; Meza ME; Rojas W; Talavera GA; Gupta S
    J Racial Ethn Health Disparities; 2018 Jun; 5(3):530-535. PubMed ID: 28634873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Additional outreach effort of providing an opportunity to obtain a kit for fecal immunochemical test during the general health check-up to improve colorectal cancer screening rate in Japan: A longitudinal study.
    Fujita M; Fujisawa T; Hata A
    PLoS One; 2020; 15(8):e0238474. PubMed ID: 32866208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT.
    Mosen DM; Liles EG; Feldstein AC; Perrin N; Rosales AG; Keast E; Smith DH
    Eur J Cancer Prev; 2014 Nov; 23(6):516-23. PubMed ID: 25203483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing Fecal Immunochemical Test Return Rates by Implementing Effective "Reminder to Complete Kit" Communication With Participants: A Quality Improvement Study.
    Prakash S; Merza N; Hosseini O; Ward H; Mansi T; Balducci M; Trammell D; Hernandez B; Obokhare I
    Cureus; 2022 May; 14(5):e25169. PubMed ID: 35746986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of community pharmacies in a population-based colorectal cancer screening program.
    Vives N; Milà N; Binefa G; Travier N; Farre A; Vidal C; Sattari M; Bagaria G; Garcia M
    Prev Med; 2021 Apr; 145():106420. PubMed ID: 33422578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of a mailed fecal immunochemical test outreach: a Medicare Advantage pilot study.
    Issaka RB; Akinsoto NO; Strait E; Chaudhari V; Flum DR; Inadomi JM
    Therap Adv Gastroenterol; 2020; 13():1756284820945388. PubMed ID: 32952612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population.
    Shepherd ME; Lecorps A; Harris-Shapiro J; Miller-Wilson LA
    J Prim Care Community Health; 2021; 12():21501327211037892. PubMed ID: 34382887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interventions to increase colorectal cancer screening adherence in low-income settings within the United States: A systematic review and meta-analysis.
    Rubin L; Okitondo C; Haines L; Ebell M
    Prev Med; 2023 Jul; 172():107522. PubMed ID: 37137414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Mailed Fecal Immunochemical Test Outreach for Patients Newly Eligible for Colorectal Cancer Screening.
    Burns S; Wang J; Somsouk M
    Dig Dis Sci; 2023 Jun; 68(6):2315-2317. PubMed ID: 36964863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.
    Green BB; Coronado GD; Schwartz M; Coury J; Baldwin LM
    Implement Sci; 2019 May; 14(1):53. PubMed ID: 31142348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized controlled trial to improve colon cancer screening in rural family medicine: an Iowa Research Network (IRENE) study.
    Levy BT; Xu Y; Daly JM; Ely JW
    J Am Board Fam Med; 2013; 26(5):486-97. PubMed ID: 24004700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.